p14arf公司
热休克蛋白90
泛素连接酶
细胞生物学
癌症研究
格尔德霉素
生物
蛋白质稳态
伴侣(临床)
衰老
泛素
热休克蛋白
化学
癌症
癌变
抑癌基因
生物化学
遗传学
医学
基因
病理
作者
Su Yeon Han,Aram Ko,Haruhisa Kitano,Chel Hun Choi,Min-Sik Lee,Jinho Seo,Junya Fukuoka,Soo‐Youl Kim,Stephen M. Hewitt,Joon‐Yong Chung,Jaewhan Song
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2016-10-29
卷期号:77 (2): 343-354
被引量:33
标识
DOI:10.1158/0008-5472.can-16-0613
摘要
The tumor suppressor function of p14ARF is regulated at a posttranslational level via mechanisms yet to be fully understood. Here, we report the identification of an unconventional p14ARF degradation pathway induced by the chaperone HSP90 in association with the E3 ubiquitin ligase C-terminus of HSP70-interacting protein (CHIP). The ternary complex of HSP90, CHIP, and p14ARF was required to induce the lysosomal degradation of p14ARF by an ubiquitination-independent but LAMP2A-dependent mechanism. Depletion of HSP90 or CHIP induced p14ARF-dependent senescence in human fibroblasts. Premature senescence observed in cells genetically deficient in CHIP was rescued in cells that were doubly deficient in CHIP and p14ARF. Notably, non-small cell lung cancer cells (NSCLC) positive for p14ARF were sensitive to treatment with the HSP90 inhibitor geldanamycin. Furthermore, overexpression of HSP90 and CHIP with a concomitant loss of p14ARF correlated with poor prognosis in patients with NSCLC. Our findings identify a relationship between p14ARF and its chaperones that suggest new therapeutic strategies in cancers that overexpress HSP90. Cancer Res; 77(2); 343-54. ©2016 AACR.
科研通智能强力驱动
Strongly Powered by AbleSci AI